Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) Director Jennifer Straumins sold 100,000 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $16.23, for a total transaction of $1,623,000.00. Following the completion of the sale, the director now directly owns 934,589 shares of the company's stock, valued at approximately $15,168,379.47. This trade represents a 9.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Jennifer Straumins also recently made the following trade(s):
- On Friday, June 13th, Jennifer Straumins sold 50,000 shares of Calumet Specialty Products Partners stock. The shares were sold at an average price of $15.08, for a total transaction of $754,000.00.
- On Thursday, June 5th, Jennifer Straumins sold 100,000 shares of Calumet Specialty Products Partners stock. The shares were sold at an average price of $13.17, for a total transaction of $1,317,000.00.
Calumet Specialty Products Partners Stock Performance
NASDAQ CLMT opened at $16.86 on Tuesday. The firm has a market cap of $1.45 billion, a PE ratio of -6.11 and a beta of 0.91. Calumet Specialty Products Partners, L.P. has a one year low of $7.68 and a one year high of $25.29. The firm's fifty day moving average is $12.25 and its two-hundred day moving average is $15.23.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last posted its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.62). The business had revenue of $993.90 million for the quarter, compared to the consensus estimate of $899.62 million. The business's revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.51) EPS. Research analysts predict that Calumet Specialty Products Partners, L.P. will post -3.02 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on CLMT shares. TD Cowen cut shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and reduced their price target for the company from $26.00 to $16.00 in a research report on Tuesday, March 4th. Bank of America started coverage on shares of Calumet Specialty Products Partners in a research report on Tuesday, May 13th. They issued a "buy" rating and a $15.00 price target for the company. Wells Fargo & Company reduced their price target on shares of Calumet Specialty Products Partners from $23.00 to $21.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. UBS Group raised shares of Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and reduced their price target for the company from $15.00 to $12.00 in a research report on Monday, March 17th. Finally, The Goldman Sachs Group reduced their price target on shares of Calumet Specialty Products Partners from $16.00 to $14.00 and set a "buy" rating for the company in a research report on Wednesday, April 30th. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $18.50.
Get Our Latest Stock Report on Calumet Specialty Products Partners
About Calumet Specialty Products Partners
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
